Latest news
Trastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMTCombination therapy improves progression-free survival for patients with metastatic dMMR colorectal cancer - Medical XpressMedical Xpress · Fri, 31 Jul 2026 02:20:02 GMTDabrafenib Plus Trametinib Improves Progression-Free Survival in BRAF V600E-Positive Differentiated Thyroid Cancer - The ASCO PostThe ASCO Post · Mon, 27 Jul 2026 14:48:53 GMT